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Abstract
Background: Mosaic Chromosome 20 ring [r(20)] is a chromosomal disorder associated with a rare syndrome
characterized by a typical seizure phenotype, a particular electroclinical pattern, cognitive impairment, behavioural
problems and absence of a consistent pattern of dysmorphology. The pathogenic mechanism underlying seizures
disorders in r(20) syndrome is still unknown. We performed a detailed clinical and genetic study on 8 patients with
r(20) chromosome, aimed at detecting the genetic mechanism underlying r(20) syndrome.
Methods: We submitted 8 subjects with a previous diagnosis of ring 20 chromosome mosaicism to a clinical re-
evaluation, followed by cytogenetic, FISH, array-CGH and molecular analyses. The genetic study was also extended
to their available parents.
Results: FISH and array-CGH experiments indicate that cryptic deletions on chromosome 20 are not the cause of
the r(20) chromosome associated disease. Moreover, no evidence of chromosome 20 uniparental disomy was
found. Analysis of FISH signals given by variant in size alphoid tandem repeats probes on the normal chromosome
20 and the r(20) chromosome in the mosaic carriers suggests that the r(20) chromosome is the same chromosome
not circularized in the “normal” cell line.
Conclusions: Higher percentages of r(20) chromosome cells were observed to be related with precocious age at
seizure onset and with resistance to antiepileptic drug treatment. Behavioural problems also seem to be associated
with higher percentages of r(20) chromosome cells. Our results suggest that an epigenetic mechanism perturbing
the expression of genes close to the telomeric regions, rather than deletion of genes located at the distal 20p and/
or 20q regions, may underlie the manifestation of r(20) syndrome.
Background
Mosaic Chromosome 20 ring [r(20)] is a chromosomal
disorder that has been associated with a rare syndrome
characterized by a typical seizure phenotype consisting
of complex partial seizures, a particular electroclinical
pattern, cognitive impairment, behavioural problems and
absence of a consistent pattern of dysmorphology [1-4].
Over 60 cases have been reported up to now, mostly
sporadic, with mosaicism for a de novo r(20) chromo-
some resulting in refractory epilepsy with non convul-
sive status epilepticus (NCSE) and cognitive problems
[5-7]. A reassessment of the published cases with [r(20)]
syndrome indicates that the development is generally
normal or mildly delayed but it is followed by cognitive
and behavioural decline after seizure onset indicating
that the clinical disorder could be interpreted as an epi-
leptic encephalopathy [8].
At the chromosomal level, r(20) chromosome replaces
one of the two chromosomes 20 in a percentage of cells,
ranging from 1 to 100% in lymphocytes. The relation
between the variable mosaicism and the clinical pheno-
type has been and is still controversial [6,9,10].
T h ep a t h o g e n i cm e c h a n i s mu n d e r l y i n gt h es e i z u r e s
disorder in r(20) syndrome is unknown. Only a few
cases have been investigated with FISH technique
oriented at detecting subtelomeric deletions of
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deletion of the 20qter epilepsy genes CHRNA4 and
KCNQ2 [4,11-14]. Here we describe the clinical presen-
tation of 8 patients, 6 sporadic cases and two family
members found to be carriers of r(20) chromosome
mosaicism. We report on the conventional cytogenetics,
FISH characterization and genotyping of chromosome
20 polymorphic markers of probands and parents aimed
at detecting the genetic mechanism underlying r(20)
syndrome. Array CGH, which has not yet been applied
to patients carrying r(20) chromosome was also used to
interrogate the overall genome of the patients and rule
out chromosome 20 copy number imbalances.
Methods
Patient recruitment
The study was approved by the Ethics Committee of
Istituto Auxologico Italiano (RC 08C703_2007), partici-
pating subjects gave informed consent and procedures
followed were in accordance with institutional guide-
lines. Eight probands were recruited for the genetic ana-
lyses by the two neurological units involved in this
study. An informed consent was also obtained from par-
ents and relatives submitted to genetic tests.
Cognitive assessments
Cognitive assessment of patients was performed using
Bayley Scales of Infant Development and WISC-R Intel-
ligence Scale for pediatric age or Wais Intelligence Scale
for Adult Age [15-17].
Video-EEG recordings
Patients underwent EEG video-polygraphic recordings
during wakefulness and sleep using a computerized EEG
System. Scalp electrodes were positioned according to
the international 10/20 system plus EMG electrodes for
deltoid muscles and/or distal muscles, electrocardiogram
and breathing effort.
We performed several video-EEG (VEEG) monitoring
and sleep recordings in each patient.
Magnetic Resonance Imaging (MRI) - Brain
Brain MRIs were obtained in FL, DG, CD, BV, PE and
BE patients. Because the imaging studies were per-
formed at different institutions, the imaging parameters
varied slightly. However, the patients underwent brain
MRI with 0.5-tesla or 1.5-tesla apparatus. Noncontrast-
enhanced sagittal, axial and coronal T1-weighted images,
and axial T2-weighted images with 4-6 mm section
thickness were available.
Cytogenetic, FISH and array-CGH analyses
The cytogenetic analysis was performed using Q-band-
ing on lymphocytes and fibroblasts from each proband
and parents, when available. Conventional protocols
were used to set up the cultures and chromosome pre-
parations. Both commercial and homemade probes were
used for the FISH analyses. The commercial probes
were pantelomeric and chromosome 20-specific a-satel-
lite DNA and subtelomeric probes (Vysis, Chicago, IL).
The FISH experiments were carried out according to
the suppliers’ protocols. FISH to detect the integrity of
the CHRNA4 and KCNQ2 regions was performed with
RCP11-939M14 and RCP11-358D14 BAC clones
selected according to the UCSC Genome Browser,
March 2006 release, and provided by the University of
Bari, Italy (Resources for Molecular Cytogenetics: http://
www.biologia.uniba.it/rmc/). The order of probes from
cen to tel is RCP11-939M14, RCP11-358D14 and 20q
subtelomeric probe (Vysis, Chicago, IL). The distance
from RCP11-939M14 to RCP11-358D14 is ~20 kb and
~500 kb from RCP11-358D14 to the 20q subtelomeric
commercial probe. BAC FISH experiments were exe-
cuted according to Lichter et al. with minor modifica-
tions[18]. Array-CGH was performed on genomic DNA
from probands, extracted from peripheral blood mono-
nucleate cells with the GenElute™ Blood Genomic DNA
kit (Sigma-Aldrich, St Louis, Missouri, USA) according
to the instructions of the supplier. The Human Genome
CGH Microarray Kit 244A was employed according to
the protocol provided by Agilent (Agilent technologies,
Santa Clara, CA). This platform is a high-resolution 60-
mer oligonucleotide-based microarray allowing genome-
wide survey and molecular profiling of genomic imbal-
ances with ~30 Kb average resolution. For chromosome
20p and 20q subtelomeric regions the average resolution
is ~30 kb and ~50 kb respectively, with the most distal
oligonucleotide on 20p and 20q located respectively at
~9 kb and ~57 kb from the chromosome ends. The
arrays were analyzed with the Agilent Scanner Control
(v 7.0) and the Feature Extraction software (v 9.5.3.1).
Graphical overview was obtained using the DNA Analy-
tics software (v4.0). The unbalanced regions pointed out
by the analysis were studied by means of the Database
of Genomic Variants http://projects.tcag.ca/variation and
the UCSC Genome Browser http://genome.ucsc.edu/,
March 2006 release.
Molecular analysis
DNA was extracted from peripheral blood leukocytes of
the probands and parents by using automated system
Tecan Freedom Evo (Mannedorf, Swizerland), Gene-
Catcher(tm) gDNA 96 × 10 ml Automated Blood Kit,
Invitrogen (Carlsbad, CA). A first panel of fluorescinated
primers, D20S117, D20S889, D20S115, D20S107,
D20S119, D20S178, D20S196, D20S100, and D20S173,
selected from the ABI Prism Linkage Mapping Set and
spanning the chromosomal regions 20p12.3-p13 and
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investigated in each trio of parents and proband. In the
familial cases (FL and FMA) and in MM, markers
D20S186, D20S112, D20S195 D20S171 were added in
order to replace the uninformative ones. PCRs were
performed according to standard protocols for the
microsatellite panel advised by Aplera (ABI PRISM(r)
Linkage Mapping Set version 2.5 Panel). PCR products
were separated by capillary electrophoresis on
th Automated ABI 310 Sequencer (PE Applied Bio-
system, Foster City, CA, USA).
Results
Clinical data
The clinical characteristics and the r(20) chromosome
percentages observed in lymphocytes and fibroblasts of
the enrolled patients are summarized in Table 1. Eight
patients (2 males, 6 females, mean age 24 years (range
3-59 years), were included in the study. A detailed clin-
ical description of patients FL, FMA and BD was pro-
vided by Canevini et al, as cases 1, 2, 3 respectively,
while that of CD and DG has recently been published
as cases 2 and 3 [4,8]. Only MM patient showed facial
dysmorphisms with frontal bossing, inner epicanthal
folds and a low nasal bridge.
A structural abnormality of the internal ear asso-
ciated with deafness has been observed in BV. Growth
retardation has been detected in BV and MM. FMA
and BD show a normal IQ, while in the remaining
cases IQ is below normal or in the lower range (see
Table 1). Epilepsy was the symptom that led to the
evaluation of all patients except for the youngest child,
MM, aged 3 years, who has been followed-up after a r
(20) mosaicism prenatal diagnosis and is not yet epilep-
tic. The average age at seizure onset was 9 years (range
4-17 years). The majority of the patients experienced
more than one seizure type, including complex partial
seizures, atypical absences, generalized tonic-clonic sei-
zures and focal motor seizures. Five patients (FL, DG,
CD, BV, PE) showed NCSE in the course of their dis-
ease. Video-EEG recordings demonstrated frontal and/
or fronto-temporal abnormalities in all patients with
epilepsy. Seizures and/or NCSE have been recorded in
5 patients (FL, DG, CD, BV, PE).
In 5 out of 7 patients, the epilepsy was drug resistant,
with very frequent seizures in most cases (Table 1).
After seizure onset, all patients except FMA and BD
developed deterioration of cognitive abilities with loss
of previously acquired skills. None of the patients
showed progressive motor impairment. Five patients
presented with behavioural problems: autistic features
with loss of social skills and impaired interpersonal
relationships were observed in FL, CD, BV. Attention
deficit was evident in FL, CD and DG, irritability in BE
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Page 3 of 11and depressive traits in BV. Brain magnetic resonance
was performed in FL, DG, CD, BV, PE and BE with nor-
mal results. FMA underwent a brain CT scan that pro-
vided normal result. Excluding the familiar case FL, all
parents were reported to be healthy.
Cytogenetic and FISH analyses
Table 1 lists the results of the conventional cytogenetic
analyses performed on our 8 patients. A de novo origin
of r(20) chromosome could be established in four cases:
CD, DG, BD and MM by the analyses of no less than 60
metaphase lymphocytes from their parents. Conversely
FL inherited the r(20) chromosome from his mother
(FMA): the maternal grandmother was excluded as
being a carrier by scoring 72 lymphocyte metaphases,
while this investigation was precluded on the deceased
maternal grandfather. The parents of the two remaining
patients, PE and BV, were unavailable for the cytoge-
netic study.
The percentage of cells with r(20) chromosome,
detected in the probands by scanning no less than 60
metaphases from peripheral blood and 30 metaphases
from skin biopsy, was found to range from 8 to 71% in
lymphocytes and from 0 to 81% in fibroblasts. Patients
FL and BD showed respectively the highest and lowest
percentages in the analyzed tissues. The percentage of
cells with r(20) chromosome was similar in peripheral
blood and fibroblasts of CD and BV, while PE showed
the widest variation. The percentage of r(20) chromo-
some cells appears to be dynamic across time as FL,
FMA and DB show on lymphocytes 71, 9 and 8% of
r(20) chromosome cells as compared to 83, 12 and 16%
which were reported eleven years before by Canevini
et al. [4], 53% of r(20) chromosome was detected on
peripheral blood at diagnosis in CD and 26% in DG as
compared with 42% and 67% respectively observed in
the present study (Table 1).
FISH investigations with a chromosome 20-specific
a-satellite DNA probes showed the derivation of the
ring chromosomes from chromosome 20 (Figure 1). The
analysis of at least 100 interphase nuclei and 60 lympho-
cyte metaphases of each patient indicated that no more
than 1% of cells were monosomic for chromosome 20
due to the loss of r(20) chromosome because of its
mitotic instability. The presence of variant in size
alphoid tandem repeats monitored by FISH signals of
different intensities (low/high) was also observed on
chromosome 20 centromeres (Figure 1). An alphoid-
specific heteromorphism suitable to discriminate
between the two homologous chromosomes 20 was
detected in DG, CD, PE and FMA patients, whereas in
FL and BV the signals were similar in size on both chro-
mosome 20 centromeres (Figure 1). Careful scoring of
about 15 metaphases from the informative patients
allowed us to distinguish the apparently normal chro-
mosome 20 from the r(20) chromosome using the
“identity” of the structure of the centromeric constric-
tion. Indeed the “low” intensity signal discriminating
r(20) chromosome from its “high” signal normal homo-
logous was present in the not “circularized” chromo-
some 20 in the cell line with normal karyotype of DG,
CD and FMA likewise the “high” intensity signal of r
(20) chromosome of PE (Figure 1).
FISH with pan-telomeric and subtelomeric specific
probes was performed on each patient with similar
results: the presence of signals on r(20) chromosome
demonstrated the integrity of the target regions in the
ring chromosome (Figure 2a and 2b) as well as in both
chromosomes 20 of the karyotypically normal cell line.
In addition the finding of gene-specific RCP11-939M14
and RCP11-358D14 BAC signals on the rearranged
chromosome as well as on both chromosomes 20 of the
karyotypically normal cell line indicated that CHRNA4
and KCNQ2 gene sequences are maintained in both cell
lines (Figure 2c and 2d).
Array-CGH analysis
Array-CGH analyses revealed a chromosome 20 normal
profile in all patients (Figure 3). Surprisingly, BV was
found to be carrier of a 1.9 Mb deletion between
67228076 and 69164712 nucleotides (hg18 NCBI
build36) on chromosome 16q22.1 (Figure 4a and 4b).
The 1.9 Mb deleted region identified in BV contains 42
genes (Figure 4b), 27 of which with a known function,
making it hard to link deletion for the genes with the
patient’s phenotype. Since the proband’sm o t h e rh a d
died, assessment of the de novo origin of the anomaly
could not be established.
Molecular analysis
Occurrence of either whole or segmental chromosome
20 uniparental disomy (UPD) was investigated by segre-
gation analysis of polymorphic loci from parents to pro-
band. In all cases the informative markers evidenced a
biparental contribution. In BV family microsatellite ana-
lysis only allowed exclusion of paternal UPD, because
the mother was deceased. Segregation analysis from FL
grandmother to FL through FMA indicated the biparen-
tal contribution of chromosome 20 and the absence of
recombination along the chromosome, which appears to
be transmitted in an identical form across two genera-
tions (Figure 5).
Discussion and Conclusion
I nt h ep r e s e n ts t u d yw eh a v ec h a r a c t e r i z e do nt h e
genetic aspects and clinical ground the largest cohort of
ring 20 patients reported till now. All patients but the
youngest one (MM, 3 years old) presented the typical
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Page 4 of 11seizure disorder associated with r(20) chromosome, with
a mean age at seizure onset of 9 years. Epilepsy onset
has been reported in paediatric, adolescent and adult
age. Patients with an early epilepsy onset (within the
first year of age) have been reviewed by Ville et al: all
exhibited severe psychomotor delay before seizure onset
and a percentage of r(20) chromosome cells ranging
from 87 to 100% [19].
More than 60 cases of patients with a non supernu-
merary r(20) chromosome mosaicism have been
reported, but the great majority have been investigated
only with conventional cytogenetic analysis.
Ring(20) syndrome is characterized by phenotypic
variability, particularly concerning dysmorphism, malfor-
mations, mental retardation and behavioural distur-
bances [20]. The severity of clinical features has been
ascribed to high percentages of r(20) chromosome
abnormal cells, ring instability and presence or absence
of chromosome 20 deleted regions [10,13,21]. Previously
reported patients showed a percentage of r(20) chromo-
some cells ranging from 1 to 100% in peripheral blood.
Generally, cases with 100% anomalous cells exhibited
more severe development and psychomotor delay, start-
ing from the first months of life, before seizure onset
[19]. Previous studies failed to reach a consensus regard-
ing the relationship between the percentage of mosai-
cism and the manifested phenotype. No correlation was
found between IQ and age at seizure onset in two inde-
pendent reports,[6,9] whereas Nishiwaki et al. [10] con-
cluded that the mosaicism ratio is significantly
associated with IQ, age at seizure onset and malforma-
tions, but not with the response to antiepileptic drug
treatment. A positive correlation between age at seizure
onset and rate of r(20) mosaicism was also observed by
Figure 1 FISH analysis with chromosome 20-specific a-satellite DNA probes. FISH results on r(20), indicating alphoid-specific
heteromorphism suitable to discriminate between the two homologous chromosomes 20 (arrowed) in DG, CD, PE and FMA patients. In FL, BV
and BD no polymorphic signals on chromosome 20 homologous have been identified. See text for explanation
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Page 5 of 11Herrgard et al. [11]. In our patient cohort the percen-
tage of r(20) chromosome cells covered a wide range,
from 8 to 71% in peripheral blood. In seven out of eight
investigated cases the percentage of r(20) chromosome
could be also computed on fibroblasts, making the level
of mosaicism representative of two different cell
lineages. Our results indicate that higher percentages of
r(20) chromosome cells are observed in probands with
younger age at seizure onset and seem also to correlate
with resistance to antiepileptic drug treatment, agreeing
with the findings of Nishiwaki et al. and Herrgard et al.
[10,11]. The two patients from our series showing a
lower degree of r(20) mosaicism developed seizures at
an older age, epilepsy was controlled and they are the
only two patients without mental impairment in adult
age. These cases further demonstrate the fundamental
role of seizures in determining cognitive impairment in
r(20) syndrome [8]. Behavioural problems also appear in
our patients to be related with higher percentages of
r(20) chromosome cells. A major malformation was
observed only in BV, who is the patient with a concur-
rent 1.9 Mb deletion on 16q chromosome (Figure 4a
and 4b), confirming that this finding is likely to be coin-
cidental and not characteristic of the r(20) mosaic
Figure 2 Example of the FISH results obtained for each proband on ring 20 chromosome. A) pan-telomeric probe; B) 20p (green signal)
and 20q (red signal) subtelomeric specific probes; C) RCP11-939M14 and D) RCP11-358D14 BAC clones targeting CHRNA4 and KCNQ2 epilepsy
genes respectively. The presence of the signals on r(20) (arrowed) demonstrates the integrity of the investigated regions. In panel C, RCP11-
939M14 clone cross-hybridizes with chromosome 15.
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Page 6 of 11Figure 3 Array-CGH chromosome 20 profile. Example of normal profile observed in all patients and magnifications of the 1,2 Mb distal 20p
and 20q regions. CHRNA4 and KCNQ2 genes on 20q are circled.
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Page 7 of 11patients in addition to the dysmorphism, which were
observed just in BV and MM.
It has been suggested that the presence of chromo-
some 20 monosomic cells generated by r(20) chromo-
some instability during mitosis might be implicated in
the phenotypic manifestations of r(20) syndrome [13] as
well as in the so call “ring syndrome” [22]. However the
FISH results on our series revealed only about 1% of
monosomic cells in each patient, different to the signifi-
cantly higher percentage (8%) detected by Elghezal et al.
[13] but in agreement with the recently reported conclu-
sions weakening the hypothesis of the “ring syndrome”
Figure 4 Array-CGH chromosome 16 profile. A) Genomic imbalances on patient BV chromosome 16, with magnification of the deleted
region and B) the contained genes.
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Page 8 of 11phenotype caused by ring instability [23]. Ring (20)
chromosome mosaicism generally represents a de novo
event. To date, only three families with several carrier
members have been published. A clinically unaffected
carrier mother transmitting the r(20) chromosome to
two siblings has been reported by Back et al. [24], while
in the familial cases described by Herrgard et al. [11]
the two siblings inherited the r(20) chromosome from
their affected mother. Canevini et al. reported a son
(FM in this study) inheriting the r(20) chromosome
from his less severely affected mother (FMA in this
study) [4]. The concomitance of a cell line with two
apparently “normal” chromosomes 20 in patients with
an inherited r(20) chromosome is still an open question.
A possible explanation is that the “normal” cell line is
isodisomic for chromosome 20. This condition may
have occurred by a rescue mechanism rectifying through
duplication of the normal chromosome 20 the monoso-
mic cell originated by loss of r(20) chromosome.
Another mechanism leading to a mosaicism with a nor-
mal cell line in r(20) chromosome inherited cases is the
trisomy rescue in a 47,+r(20) conceptus consequent to a
random loss of r(20) chromosome or normal chromo-
some 20 in different cells during mitosis in early
development. We have thus searched for putative
UPD20 in our mosaic familial and de novo cases by seg-
regation analysis of chromosome 20 microsatellites from
parents to probands. To the best of our knowledge, this
is the first study in which UPD20 has been evaluated in
patients affected by r(20) disease. Our results do not
support the UPD20 hypothesis, although they suggest
through the haplotype signature that the r(20) chromo-
some is the same chromosome that appears and is not
circularized in the “normal” cell line (Figure 5). This
hypothesis is not contradicted by the FISH results
obtained using a 20-specific alphoid probe able to visua-
lize different signal intensities when the two centromeric
constrictions are built up with a different number of
alphoid repeats (Figure 1). This finding might have the
following implications: a) r(20) patients have two cell
lines differing only on a morphological but not a genetic
point of view; b) one of the two chromosomes 20 has a
genetic motif, yet unknown, inducing both the “circular-
ization” and the “re-opening”. The direct physical link
between distal 20p and 20q segments in the ring struc-
ture may disturb the correct expression or the regula-
tion of genes located nearly the telomeric regions. It
may also prime the phenotypic manifestation of the
Figure 5 Results of segregation analysis from parents to probands of chromosome 20 microsatellites.
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Page 9 of 11syndrome. The mosaic condition of the patient inherit-
ing the r(20) chromosome from his mother may evi-
dence the plasticity of the circularized chromosome.
To date only 10 r(20) patients, including 3 familial
cases [11], have been investigated by FISH techniques
[4,11-13,21,25] and one with telomere PRINS (primer in
situ DNA synthesis) [26]. Three out of 7 cases were
found to carry a r(20) chromosome with deletion of the
telomeric regions [13,21,26]. In 9 probands, the subtelo-
meric 20p and 20q regions have been studied and the
r(20) chromosome has been shown to maintain these
sequences in all carriers [4,11,13,14] but one [25].
Ring(20) chromosome without deletion of the
CHRNA4 and KCNQ2 epilepsy genes was found in the
only two patients so far investigated for this aspect
[12,13]. In our series of patients FISH analyses indicated
no deletions of the telomeric and subtelomeric chromo-
s o m e2 0r e g i o n so rd e l e t i o no fC H R N A 4a n dK C N Q 2
genes. However, small deletions in their promoters or in
regulatory regions can’t be excluded. No evidence for
loss of chromosome 20 genetic material was also pro-
vided by the array-CGH analysis, even if the possibility
of a subtle submicroscopic deletion on r(20) chromo-
some can’t be ruled out, since array-CGH may fail to
detected low level r(20) cell mosaicism.
Our wide genetic study includes UPD20 evaluation and
array-CGH analysis which had never been performed
before on r(20) patients. We speculate that the mechan-
ism/mechanisms underlying the seizure disorder in r(20)
carriers must be related on the conversion of ring 20 to
normal chromosome 20 morphology and vice versa. This
speculation should be corroborated by studying further
familial cases. Moreover, the hypothesis that tandem
repeats of telomere DNA forming a heterochromatic
structure may silence subtelomeric CHRNA4 and
KCNQ2 genes or their regulatory components should be
investigated. The presence of other epileptic genes map-
ping to chromosome 20 also deserves to be considered in
the future within the panel of players in the pathogenetic
cascade responsible for r(20) syndrome manifestations.
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